EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
| Formula | C16H17N7O2S |
| Net Charge | 0 |
| Average Mass | 371.426 |
| Monoisotopic Mass | 371.11644 |
| SMILES | CCS(=O)(=O)N1CC(CC#N)(n2cc(-c3ncnc4nccc34)cn2)C1 |
| InChI | InChI=1S/C16H17N7O2S/c1-2-26(24,25)22-9-16(10-22,4-5-17)23-8-12(7-21-23)14-13-3-6-18-15(13)20-11-19-14/h3,6-8,11H,2,4,9-10H2,1H3,(H,18,19,20) |
| InChIKey | XUZMWHLSFXCVMG-UHFFFAOYSA-N |
| Wikipedia |
|---|
| Roles Classification |
|---|
| Biological Roles: | antiviral agent A substance that destroys or inhibits replication of viruses. EC 2.7.10.2 (non-specific protein-tyrosine kinase) inhibitor An EC 2.7.10.* (protein-tyrosine kinase) inhibitor that specifically blocks the action of non-specific protein-tyrosine kinase (EC 2.7.10.2). immunosuppressive agent An agent that suppresses immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-cells or by inhibiting the activation of helper cells. In addition, an immunosuppressive agent is a role played by a compound which is exhibited by a capability to diminish the extent and/or voracity of an immune response. |
| Applications: | anti-inflammatory agent Any compound that has anti-inflammatory effects. antirheumatic drug A drug used to treat rheumatoid arthritis. immunosuppressive agent An agent that suppresses immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-cells or by inhibiting the activation of helper cells. In addition, an immunosuppressive agent is a role played by a compound which is exhibited by a capability to diminish the extent and/or voracity of an immune response. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| baricitinib (CHEBI:95341) has role anti-inflammatory agent (CHEBI:67079) |
| baricitinib (CHEBI:95341) has role antirheumatic drug (CHEBI:35842) |
| baricitinib (CHEBI:95341) has role antiviral agent (CHEBI:22587) |
| baricitinib (CHEBI:95341) has role EC 2.7.10.2 (non-specific protein-tyrosine kinase) inhibitor (CHEBI:76617) |
| baricitinib (CHEBI:95341) has role immunosuppressive agent (CHEBI:35705) |
| baricitinib (CHEBI:95341) is a azetidines (CHEBI:38777) |
| baricitinib (CHEBI:95341) is a nitrile (CHEBI:18379) |
| baricitinib (CHEBI:95341) is a pyrazoles (CHEBI:26410) |
| baricitinib (CHEBI:95341) is a pyrrolopyrimidine (CHEBI:38670) |
| baricitinib (CHEBI:95341) is a sulfonamide (CHEBI:35358) |
| IUPAC Name |
|---|
| {1-(ethylsulfonyl)-3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]azetidin-3-yl}acetonitrile |
| INNs | Source |
|---|---|
| baricitinib | WHO MedNet |
| baricitinibum | WHO MedNet |
| baricitinib | WHO MedNet |
| baricitinib | WHO MedNet |
| Synonyms | Source |
|---|---|
| INCB028050 | ChemIDplus |
| LY 3009104 | ChemIDplus |
| INCB 028050 | ChemIDplus |
| LY3009104 | ChemIDplus |
| LY-3009104 | DrugBank |
| INCB-028050 | DrugBank |
| Brand Name | Source |
|---|---|
| Olumiant | ChemIDplus |
| Manual Xrefs | Databases |
|---|---|
| LSM-6709 | LINCS |
| DB11817 | DrugBank |
| HMDB0248873 | HMDB |
| D10308 | KEGG DRUG |
| Baricitinib | Wikipedia |
| 26373084 | ChemSpider |
| 3JW | PDBeChem |
| Registry Numbers | Sources |
|---|---|
| CAS:1187594-09-7 | ChemIDplus |
| Citations |
|---|